Alzinova AB Cash Flow Conversion Efficiency

Latest as of March 2026: -0.113x

Alzinova AB cash flow conversion efficiency. Based on the latest financial reports, Alzinova AB (ALZ) has a cash flow conversion efficiency ratio of -0.113x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-16.80 Million ≈ $-1.81 Million USD) by net assets (Skr148.71 Million ≈ $16.00 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Alzinova AB (2014–2025)

Cash flow conversion efficiency of Alzinova AB from 2014 to 2025. This chart illustrates how Alzinova AB's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Alzinova AB (ALZ) stock price for real-time trading data and today's change.

Alzinova AB Cash Flow Conversion Ratio Explained

Alzinova AB cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Alzinova AB Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Alzinova AB ranked by their cash flow conversion efficiency. Also see Alzinova AB (ALZ) total market value for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
TME Pharma N.V. PA:ALTME	0.353x
GLG Corp Ltd AU:GLE	0.125x
NGS Group AB (publ) ST:NGS	0.030x
Kiora Pharmaceuticals Inc NASDAQ:KPRX	-0.112x
Knightscope Inc NASDAQ:KSCP	-0.382x
Close Brothers Group plc LSE:CBG	0.124x
Getty Images Holdings Inc. NYSE:GETY	0.067x
Mount Burgess Mining NL AU:MTB	0.097x

Annual Cash Flow Conversion Efficiency for Alzinova AB (2014–2025)

The table below shows the annual cash flow conversion efficiency of Alzinova AB from 2014 to 2025. Review Alzinova AB free cash flow ratio to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	Skr121.96 Million ≈ $13.12 Million	Skr-13.03 Million ≈ $-1.40 Million	-0.107x	+34.72%
2024-12-31	Skr123.82 Million ≈ $13.33 Million	Skr-20.27 Million ≈ $-2.18 Million	-0.164x	-22.49%
2023-12-31	Skr113.86 Million ≈ $12.25 Million	Skr-15.21 Million ≈ $-1.64 Million	-0.134x	-36.72%
2022-12-31	Skr105.53 Million ≈ $11.36 Million	Skr-10.31 Million ≈ $-1.11 Million	-0.098x	+11.95%
2021-12-31	Skr88.47 Million ≈ $9.52 Million	Skr-9.82 Million ≈ $-1.06 Million	-0.111x	-70.10%
2020-12-31	Skr96.02 Million ≈ $10.33 Million	Skr-6.27 Million ≈ $-674.29K	-0.065x	+2.98%
2019-12-31	Skr59.11 Million ≈ $6.36 Million	Skr-3.98 Million ≈ $-427.85K	-0.067x	-8.08%
2018-12-31	Skr63.75 Million ≈ $6.86 Million	Skr-3.97 Million ≈ $-426.95K	-0.062x	+14.16%
2017-12-31	Skr29.39 Million ≈ $3.16 Million	Skr-2.13 Million ≈ $-229.31K	-0.072x	+16.33%
2016-12-31	Skr31.90 Million ≈ $3.43 Million	Skr-2.76 Million ≈ $-297.46K	-0.087x	+44.29%
2015-12-31	Skr20.63 Million ≈ $2.22 Million	Skr-3.21 Million ≈ $-345.40K	-0.156x	+66.23%
2014-12-31	Skr1.55 Million ≈ $167.09K	Skr-715.19K ≈ $-76.97K	-0.461x	--

About Alzinova AB

ST:ALZ Sweden Biotechnology

Market Cap

$7.34 Million

Skr68.19 Million SEK

Market Cap Rank

#27666 Global

#601 in Sweden

Share Price

Skr0.34

Change (1 day)

+0.30%

52-Week Range

Skr0.34 - Skr1.92

All Time High

Skr26.90